Actief in pharmaceutische sector?
InnovFin Infectious Diseases aims to stimulate investments in the development of innovative vaccines, drugs, medical and diagnostic devices or novel research infrastructures for infectious diseases. The EIB provides loans between EUR 7.5m and EUR 75m. Final recipients will be project developers that have successfully completed the pre-clinical stage and would now require clinical validation or be ready for later stage clinical trials.
Voor meer informatie download InnovFin Infectious Diseases
Van idee naar productie - de rol van 3D printen en Additive Manufacturing & Algemene Leden Vergadering